Clinical Trial Update: Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the adhesion of rotigotine-containing transdermal patches in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Rotigotine patch (rotigotine)

Snippet

Sponsor: SocraTec R&D GmbH | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED